EDMONTON, Alberta--(BUSINESS WIRE)--CanBiocin Inc, a contract research microbiology services company and developer of innovative and socially beneficial lactic acid bacteria based products, announced that its Edmonton facility has received formal recognition from the Standards Council of Canada (SCC) for its compliance with the Organization for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practice (GLP).
GLP is a quality system concerned with the organizational processes and conditions under which health studies are planned, performed, monitored, recorded, archived, and reported. CanBiocin Inc. has the capacity to conduct a range of microbiological, molecular and tissue culture contract studies for clients in the health, food and environment industries.
“After an extensive review by the SCC, we are very pleased to have received this recognition for our facility, which acknowledges the high level of quality and compliance maintained in our laboratory,” stated Dr. Michael Stiles, Chief Scientific Officer. “We look forward to continuing to serve our clients who are seeking international registration by completing quality studies at our recognized facilities.”
Earning GLP (facility only) recognition from the SCC assures that CanBiocin Inc. has the appropriate infrastructure and standard operating procedures (SOPs) in place to run GLP compliant studies. This recognition is an important step for CanBiocin Inc. in providing excellent service to their clients. CanBiocin Inc. will apply to earn full GLP certification.
About CanBiocin Inc.
CanBiocin was formed in 1998 as a University of Alberta spin-off company to commercialize novel technologies developed from research conducted by professors Michael Stiles, Lynn McMullen and John Vederas. The technologies are based on the application of lactic acid bacteria (LAB) for food safety and to enhance animal and human health.
Visit www.canbiocin.ca for more information.